Description
EXPRESS REPORT - 2 PHARMACY ORDERS DALFAMPRIDINE (AMPYRA) 10MG PURCHASE ORDERS REPORTED: 554A30329,554A30551
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-04-25+$97,228= $97,228
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-04-25 | +$97,228 | $97,228 | EXPRESS REPORT - 2 PHARMACY ORDERS DALFAMPRIDINE (AMPYRA) 10MG PURCHASE ORDERS REPORTED: 554A30329,554A30551 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI R5D3FUPFFPK4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77024N0067 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $493,607 | FY2024 |
| 36E79724A0005 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C77024N0027 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $444,505 | FY2024 |
| 36F79723D0194 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36E79723A0011 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36C77023N0057 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $529,877 | FY2023 |
Other recipients under 6505 from 259-NETWORK CONTRACT OFFICE 19 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25916E2832 | GRIFOLS USA LLC | 259-NETWORK CONTRACT OFFICE 19 | $16,949 | FY2016 |
| VA25916P2108 | BAXALTA US INC. | 259-NETWORK CONTRACT OFFICE 19 | $6,212 | FY2016 |
| VA25916E2677 | GRIFOLS THERAPEUTICS LLC | 259-NETWORK CONTRACT OFFICE 19 | $12,066 | FY2016 |
| VA25916P1705 | MCKESSON CORPORATION | 259-NETWORK CONTRACT OFFICE 19 | $11,043 | FY2016 |
| VA25916E2674 | CAREMARK RX, L.L.C. | 259-NETWORK CONTRACT OFFICE 19 | $17,262 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25913F4506_3600_V797P5233B_3600 · retrieved 2026-09-26.